ATE318922T1 - Zielgerichtete integration in chromosomen mittels retroviraler vektoren - Google Patents
Zielgerichtete integration in chromosomen mittels retroviraler vektorenInfo
- Publication number
- ATE318922T1 ATE318922T1 AT99932760T AT99932760T ATE318922T1 AT E318922 T1 ATE318922 T1 AT E318922T1 AT 99932760 T AT99932760 T AT 99932760T AT 99932760 T AT99932760 T AT 99932760T AT E318922 T1 ATE318922 T1 AT E318922T1
- Authority
- AT
- Austria
- Prior art keywords
- chromosomes
- retroviral vectors
- targeted integration
- gene therapy
- relates
- Prior art date
Links
- 230000001177 retroviral effect Effects 0.000 title abstract 2
- 239000013598 vector Substances 0.000 title abstract 2
- 210000000349 chromosome Anatomy 0.000 title 1
- 230000010354 integration Effects 0.000 title 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 230000009395 genetic defect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Complex Calculations (AREA)
- Feedback Control In General (AREA)
- Compression Or Coding Systems Of Tv Signals (AREA)
- Electrotherapy Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199801016 | 1998-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE318922T1 true ATE318922T1 (de) | 2006-03-15 |
Family
ID=8100053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99932760T ATE318922T1 (de) | 1998-07-01 | 1999-06-30 | Zielgerichtete integration in chromosomen mittels retroviraler vektoren |
Country Status (7)
Country | Link |
---|---|
US (1) | US6656727B2 (de) |
EP (1) | EP1092035B1 (de) |
JP (1) | JP2002519069A (de) |
AT (1) | ATE318922T1 (de) |
AU (1) | AU4903099A (de) |
DE (1) | DE69930123T2 (de) |
WO (1) | WO2000001835A2 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040235173A1 (en) * | 2000-07-03 | 2004-11-25 | Gala Design, Inc. | Production of host cells containing multiple integrating vectors by serial transduction |
CA2413156C (en) * | 2000-07-03 | 2009-08-18 | Gala Design, Inc. | Expression vectors |
US20030224415A1 (en) * | 2001-06-29 | 2003-12-04 | Gala Design, Inc. | Selection free growth of host cells containing multiple integrating vectors |
AU2001271614B2 (en) * | 2000-07-03 | 2007-05-31 | Catalent Pharma Solutions, Llc | Host cells containing multiple integrating vectors |
US7384738B2 (en) * | 2002-03-28 | 2008-06-10 | Bremel Robert D | Retrovirus-based genomic screening |
US20040038304A1 (en) * | 2002-03-28 | 2004-02-26 | Gala Design, Inc. | Antibody libraries |
US20050221429A1 (en) * | 2004-01-16 | 2005-10-06 | Cardinal Health Pts, Llc | Host cells containing multiple integrating vectors comprising an amplifiable marker |
US20060233757A1 (en) * | 2004-08-27 | 2006-10-19 | Wendy Maury | Vectors with viral insulators |
ES2653843T3 (es) | 2004-09-02 | 2018-02-09 | Wyeth Llc | Sistemas y procedimientos de producción de proteínas |
WO2006078431A2 (en) * | 2004-12-22 | 2006-07-27 | The University Of Iowa Research Foundation | Compositions and methods related to modified retroviral vectors for restricted, site specific integration |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
US5650309A (en) | 1995-05-16 | 1997-07-22 | The Regents Of The University Of California | Viral vectors |
US5801030A (en) * | 1995-09-01 | 1998-09-01 | Genvec, Inc. | Methods and vectors for site-specific recombination |
EP1005561A4 (de) * | 1997-03-21 | 2004-03-31 | Enzo Therapeutics Inc A Fully | Vektor, virale vektoren und verpackungszelllinien zur deren vermehrung |
US6251677B1 (en) * | 1997-08-25 | 2001-06-26 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV virus and methods of use thereof |
-
1999
- 1999-06-30 JP JP2000558225A patent/JP2002519069A/ja active Pending
- 1999-06-30 EP EP99932760A patent/EP1092035B1/de not_active Expired - Lifetime
- 1999-06-30 AT AT99932760T patent/ATE318922T1/de not_active IP Right Cessation
- 1999-06-30 AU AU49030/99A patent/AU4903099A/en not_active Abandoned
- 1999-06-30 WO PCT/EP1999/004521 patent/WO2000001835A2/en active IP Right Grant
- 1999-06-30 DE DE69930123T patent/DE69930123T2/de not_active Expired - Fee Related
-
2000
- 2000-12-29 US US09/752,110 patent/US6656727B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2002519069A (ja) | 2002-07-02 |
AU4903099A (en) | 2000-01-24 |
DE69930123D1 (de) | 2006-04-27 |
EP1092035B1 (de) | 2006-03-01 |
WO2000001835A2 (en) | 2000-01-13 |
DE69930123T2 (de) | 2006-10-12 |
WO2000001835A3 (en) | 2000-04-06 |
US6656727B2 (en) | 2003-12-02 |
EP1092035A2 (de) | 2001-04-18 |
US20010043921A1 (en) | 2001-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG165153A1 (en) | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use | |
ATE335086T1 (de) | Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten | |
GB2405406B (en) | Viral vectors | |
DE69930123D1 (de) | Zielgerichtete integration in chromosomen mittels retroviraler vektoren | |
DE69619110D1 (de) | Adenovirale vektoren für die gentherapie | |
ATE382694T1 (de) | Vektoren und methoden zum gentransfer in zellen | |
DE69434663D1 (de) | Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt | |
TR200103711T2 (tr) | Homeostas ve adaptasyondaki proteinleri kodlayan corynebacterıum glutamıcum genleri. | |
DE60023860D1 (de) | Verfahren zur herstellung von rekombinanten peptiden | |
DE69840439D1 (de) | Zielgerichtete genveraenderung mit parvoviralen vektoren | |
DE60129069D1 (de) | Hepatitis B Virus Vektoren für Gentherapie | |
ES2152313T3 (es) | Gen grb-3-3, sus variantes y sus utilizaciones. | |
ATE532861T1 (de) | Expressionsvektor | |
DE69928395D1 (de) | Cyclin-e2 proteine und dafür kodierende gene | |
ES2168459T3 (es) | Secuencias amplificadoras derivadas del gen de la desmina, vectores que llevan estas secuencias y sus utilizaciones para la produccion de proteinas. | |
WO2005034876A3 (en) | Use of cell lines to produce active therapeutic proteins | |
FI972325A0 (fi) | Rekombinatkonstruktion foer oekning av genexpression hos vaexter | |
ATE288488T1 (de) | Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen | |
ZA200404424B (en) | Genes encoding for genetic stability, gene expression and folding proteins. | |
DE60333001D1 (de) | Vac-bac-shuttlevektor-system | |
DE50304957D1 (de) | Rekombinante virale vektoren zur tetracyclinregulierbaren genexpression | |
GB2358865A (en) | Targeted gene modification by parvoviral vectors | |
ATE441708T1 (de) | An der zytokininsynthese beteiligte proteine codierende gene | |
HUP0400915A2 (hu) | Növényi reprodukciós proteinek | |
ATE311205T1 (de) | Verwendung von viralen vektoren und geladenen molekülen für die gentherapie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1092035 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |